Skip to main content
OpenTrials
Completed

NCT Number: NCT03136939

Study of IGRP-specific T Cell in Peripheral Blood of Type 1 Diabetes Mellitus

10 type 1 diabetes, 10 type 2 diabetes and 10 healthy controls matched with age and sex were enrolled in our study and their periphera blood mononuclear cells (PBMC) were isolated. We implemented ELISPOT(Enzyme-linked Immunospot Assay) to detect the interferon-γ (IFN-γ)which secreted by IGRP-specific T cell. Results were compared between these groups.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Endocrinology, the First Affiliated Hospital to Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310003, China

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • the criteria of type 1 and type 2 diabetes

Exclusion criteria

  • no diabetes

Treatment and study plan

No intervention

Other

No intervention

Primary outcomes

  1. the rate of positive reactivation against the IGRP epitopes

    Time frame: 5 months

Sponsors and collaborators

Lead sponsor

First Affiliated Hospital of Zhejiang University

Other

Registry information

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
May 2, 2017
Registry last updated
Jul 2, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.